Seeking Alpha

Ocular Therapeutix Q2 results

  • Ocular Therapeutix (NASDAQ:OCUL) Q2 results: Revenues: $0.1M; Operating Expenses: $6.0M (+102.2%); Net Loss: ($6.4M) (-106.4%); Loss Per Share: ($2.10) (-76.5%); Quick Assets: $19.9M (+13.9%).
  • No financial guidance given.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: